Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||
| Cash income from operating activities | -18.40%9.8K | -40.75%12.01K | -86.20%20.27K | 193.70%146.85K | 50K | |||
| Revenue from customers | ---- | 387.37%9.8K | --2.01K | ---- | ---- | ---- | ---- | ---- |
| Other cash income from operating activities | ---- | ---- | -50.67%10K | -86.20%20.27K | 193.70%146.85K | --50K | ---- | ---- |
| Cash paid | -49.32%-6.82M | -182.73%-4.57M | 23.16%-1.62M | -175.36%-2.1M | -144.83%-763.61K | 81.52%-311.9K | -12.42%-1.69M | -1.5M |
| Payments to suppliers for goods and services | -49.32%-6.82M | -182.73%-4.57M | 23.16%-1.62M | -175.36%-2.1M | -144.83%-763.61K | 81.52%-311.9K | -12.42%-1.69M | ---1.5M |
| Direct interest received | 65.93%701.66K | 80.54%422.88K | 1,255.47%234.23K | -72.17%17.28K | -63.67%62.09K | -51.69%170.89K | 123.42%353.72K | --158.32K |
| Operating cash flow | -47.98%-6.12M | -201.97%-4.14M | 33.68%-1.37M | -272.31%-2.07M | -509.48%-554.67K | 93.18%-91.01K | 0.67%-1.33M | ---1.34M |
| Investing cash flow | ||||||||
| Cash flow from continuing investing activities | -527.19%-46.98M | 25.07%-7.49M | -37.24%-10M | 13.34%-7.28M | -116.62%-8.4M | 43.96%-3.88M | 28.53%-6.92M | -9.69M |
| Capital expenditure reported | -536.93%-47.19M | 25.38%-7.41M | -34.87%-9.93M | 13.78%-7.36M | -131.88%-8.54M | 62.52%-3.68M | -5.05%-9.82M | ---9.35M |
| Net PPE purchase and sale | -2.40%-82.58K | -21.54%-80.64K | -235.19%-66.35K | -222.96%-19.79K | -217.96%-6.13K | 107.52%5.2K | 79.46%-69.11K | ---336.53K |
| Net investment purchase and sale | --298.75K | ---- | ---- | -29.45%98.49K | 168.74%139.59K | ---203.06K | ---- | ---- |
| Net other investing changes | ---- | ---- | 117.28%1.94M | -14.14%893.26K | -47.17%1.04M | -33.66%1.97M | --2.97M | ---- |
| Cash from discontinued investing activities | ||||||||
| Investing cash flow | -527.19%-46.98M | 25.07%-7.49M | -37.24%-10M | 13.34%-7.28M | -116.62%-8.4M | 43.96%-3.88M | 28.53%-6.92M | ---9.69M |
| Financing cash flow | ||||||||
| Cash flow from continuing financing activities | 234.45%52.93M | 316,617.16%15.83M | -100.02%-5K | 453.02%25.68M | 66.49%4.64M | 865.79%2.79M | -98.94%288.75K | 27.13M |
| Net issuance payments of debt | ---- | --904.23K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net common stock issuance | -70.80%4.36M | 298,532.64%14.92M | -100.02%-5K | 453.02%25.68M | 66.49%4.64M | 865.79%2.79M | -98.94%288.75K | --27.13M |
| Net other financing activities | --48.57M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||
| Financing cash flow | 234.45%52.93M | 316,617.16%15.83M | -100.02%-5K | 453.02%25.68M | 66.49%4.64M | 865.79%2.79M | -98.94%288.75K | --27.13M |
| Net cash flow | ||||||||
| Beginning cash position | 39.45%14.85M | -51.64%10.65M | 286.98%22.02M | -43.14%5.69M | -10.57%10.01M | -41.60%11.19M | 525.51%19.16M | --3.06M |
| Current changes in cash | -103.94%-165.4K | 136.94%4.2M | -169.63%-11.37M | 478.30%16.33M | -265.10%-4.32M | 85.16%-1.18M | -149.51%-7.97M | --16.09M |
| End cash Position | -1.11%14.68M | 39.45%14.85M | -51.64%10.65M | 286.98%22.02M | -43.14%5.69M | -10.57%10.01M | -41.60%11.19M | --19.16M |
| Free cash from | -359.29%-53.39M | -2.29%-11.63M | -20.31%-11.37M | -3.82%-9.45M | -141.15%-9.1M | 66.39%-3.77M | -1.77%-11.23M | ---11.03M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |